Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL)
DOI: 10.1093/bjd/ljaf268Author: Charlée Nardin et al.Published: 2026-1-27

Forum Forums Available Download: DOI Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL)

DOI: 10.1093/bjd/ljaf268Author: Charlée Nardin et al.Published: 2026-1-27

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #1759
    miltonbyteMiltonByte
    Participant

    Title: Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL)
    Journal: British Journal of Dermatology
    Authors: Charlée Nardin, Charlotte Cavalieri, Céleste Lebbé, Emilie Gérard, Marc Puyraveau, Rémi Vergara, Eve Maubec, Nora Kramkimel, Candice Lesage, Jacques Rouanet, Bertille Bonniaud, Eve Puzenat, Dragos Popescu, Barouyr Baroudjian, Yannick Le Corre, Philippe Saiag, Florence Brunet-Possenti, Mélanie Saint-Jean, Henri Montaudié, Mona Amini-Adle, Samy Belkaïd, Florent Grange, Sandrine Mansard, Claudia-Luisa Béjar, Sophie Darras, Cécile Pagès, Emilie Tournier, Elisa Funck-Brentano, Francois Aubin
    Date: 2026-1-27
    DOI: 10.1093/bjd/ljaf268
    Source: Oxford University Press (OUP)
    Source URL: https://doi.org/10.1093/bjd/ljaf268

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.